Hosier, G.W. and Touma, N.J. 2017. Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia. Canadian Urological Association Journal. 11, 5 (May 2017), E237–9. DOI:https://doi.org/10.5489/cuaj.4316.